Fairly disappointing earnings from the likes of Royal Dutch Shell and AstraZeneca did little to prompt much enthusiasm in Europe.

NPR: Markets Edgy As US Payrolls Loom

As with any vaccine, the aim is to prompt the immune system to recognise this outer shell and destroy the pathogen before it has time to lock onto cells and infect them with its genetic material.

BBC: Synchrotron yields 'safer' vaccine